Pernille B.
- Country
- Norway
- Department
- Rheumatology
Research Overview
- Phase 4 Randomized Trial of Maintenance vs Tapered TNF‑α Inhibitor (adalimumab, etanercept, golimumab) Monotherapy in Juvenile Idiopathic Arthritis with Inactive Disease
- Evaluation of Intra-Articular Triamcinolone Hexacetonide Injections in Juvenile Idiopathic Arthritis Patients Initiating Tumor Necrosis Factor Inhibitor Therapy
Data & Insights
Has run more than one trial at 1 of 7 partner sites.
Specializations
Pediatric Rheumatology
The investigator specializes in the treatment of Juvenile Idiopathic Arthritis (JIA), focusing on innovative therapeutic approaches for pediatric patients with inflammatory joint conditions.
- Inflammatory Joint Disorders in Children
- Autoimmune Disease Management
- Pediatric Rheumatic Conditions
Their clinical interests extend to advanced therapeutic interventions in pediatric rheumatology, particularly in managing chronic inflammatory conditions.
Therapeutic Interventions
Expertise in intra-articular treatment approaches and the application of biological therapies for pediatric rheumatic conditions.
- Joint Injection Techniques
- Biological Therapy Administration
- Combined Treatment Strategies
The investigator focuses on developing effective treatment protocols that combine different therapeutic modalities.
Disease Management
Specialized in achieving sustained disease control through comprehensive treatment approaches in pediatric rheumatic conditions.
- Disease Activity Assessment
- Long-term Outcome Monitoring
- Treatment Response Evaluation
Their work emphasizes the importance of achieving and maintaining inactive disease states in pediatric patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.